Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials

Although dual HER-2 blockade treatment could offer greater clinical efficacy in breast cancer, the risk of severe toxicities of special interest related to this combined regimen in breast cancer remained unknown. We systematically searched public databases (MEDLINE, EMBASE, Cochrane library) to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Shuai, Tian, Wuguo, Gao, Bo, Jiang, Yan, Zhang, Xiaohua, Zhang, Shu, Guo, Lingji, Zhao, Jianjie, Zhang, Gang, Hu, Chunyan, Yan, Jie, Luo, Donglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386734/
https://www.ncbi.nlm.nih.gov/pubmed/28199966
http://dx.doi.org/10.18632/oncotarget.15252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386734/
https://www.ncbi.nlm.nih.gov/pubmed/28199966
http://dx.doi.org/10.18632/oncotarget.15252

Ejemplares similares